Diploma PLC (LON:DPLM - Get Free Report) insider Ian El-Mokadem acquired 500 shares of the business's stock in a transaction dated Monday, March 24th. The stock was purchased at an average price of GBX 3,948 ($51.11) per share, for a total transaction of £19,740 ($25,556.71).
Diploma Stock Down 0.3 %
Shares of Diploma stock opened at GBX 3,970 ($51.40) on Wednesday. Diploma PLC has a twelve month low of GBX 3,372 ($43.66) and a twelve month high of GBX 4,808 ($62.25). The stock has a market cap of £5.30 billion, a price-to-earnings ratio of 45.63, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17. The company has a fifty day moving average price of GBX 4,385.96 and a 200 day moving average price of GBX 4,379.51.
Diploma Increases Dividend
The business also recently disclosed a dividend, which was paid on Friday, January 31st. Shareholders of record on Thursday, January 16th were paid a dividend of GBX 42 ($0.54) per share. This represents a dividend yield of 0.93%. The ex-dividend date of this dividend was Thursday, January 16th. This is a boost from Diploma's previous dividend of $17.30. Diploma's payout ratio is currently 65.52%.
Analyst Ratings Changes
Separately, JPMorgan Chase & Co. increased their target price on shares of Diploma from GBX 4,370 ($56.58) to GBX 4,420 ($57.22) and gave the stock a "neutral" rating in a research report on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, Diploma has a consensus rating of "Moderate Buy" and a consensus price target of GBX 4,567.50 ($59.13).
Check Out Our Latest Research Report on DPLM
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
